dapsone has been researched along with Hematologic Malignancies in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among 167 pediatric patients treated for hematologic malignancies or aplastic anemia who received dapsone for PCP prophylaxis, demographic and dapsone treatment data were retrospectively collected." | 7.77 | Dapsone-induced methemoglobinemia: a dose-related occurrence? ( Esbenshade, AJ; Friedman, DL; Ho, RH; Shintani, A; Smith, LA; Zhao, Z, 2011) |
| "Among 167 pediatric patients treated for hematologic malignancies or aplastic anemia who received dapsone for PCP prophylaxis, demographic and dapsone treatment data were retrospectively collected." | 3.77 | Dapsone-induced methemoglobinemia: a dose-related occurrence? ( Esbenshade, AJ; Friedman, DL; Ho, RH; Shintani, A; Smith, LA; Zhao, Z, 2011) |
| "Dapsone may be used for Pneumocystis jirovecii pneumonia (PJP) prophylaxis in hematology patients receiving immunosuppressive therapy or after hematopoietic stem cell transplant (HSCT) in the setting of trimethoprim-sulfamethoxazole (TMP-SMX) adverse drug reaction (ADR) history." | 1.48 | Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients. ( Pisasale, D; Trubiano, JA; Urbancic, KF; Wight, J, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Urbancic, KF | 1 |
| Pisasale, D | 1 |
| Wight, J | 1 |
| Trubiano, JA | 1 |
| Subramaniam, A | 1 |
| Corallo, C | 1 |
| Nagappan, R | 1 |
| Esbenshade, AJ | 1 |
| Ho, RH | 1 |
| Shintani, A | 1 |
| Zhao, Z | 1 |
| Smith, LA | 1 |
| Friedman, DL | 1 |
| Sangiolo, D | 1 |
| Storer, B | 1 |
| Nash, R | 1 |
| Corey, L | 1 |
| Davis, C | 1 |
| Flowers, M | 1 |
| Hackman, RC | 1 |
| Boeckh, M | 1 |
| Vasconcelles, MJ | 1 |
| Bernardo, MV | 1 |
| King, C | 1 |
| Weller, EA | 1 |
| Antin, JH | 1 |
1 trial available for dapsone and Hematologic Malignancies
| Article | Year |
|---|---|
Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Antifungal Agents; Bone Ma | 2000 |
4 other studies available for dapsone and Hematologic Malignancies
| Article | Year |
|---|---|
Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients.
Topics: Aged; Anemia, Hemolytic; Anti-Infective Agents; Antibiotic Prophylaxis; Dapsone; Female; Hematologic | 2018 |
Dapsone-associated methaemoglobinaemia in patients with a haematologic malignancy.
Topics: Adult; Aged; Anti-Infective Agents; Dapsone; Female; Hematologic Neoplasms; Humans; Male; Methemoglo | 2010 |
Dapsone-induced methemoglobinemia: a dose-related occurrence?
Topics: Anemia, Aplastic; Anti-Infective Agents; Child; Child, Preschool; Cohort Studies; Cross-Sectional St | 2011 |
Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: a case-control study.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Case-Control Studies; Child; Child, Preschool; Dapso | 2005 |